GlassScriptPhysician profile
Mauro Gasparini
NPI 1871686691
$10,865.12
in general payments reported to CMS, 2019-2025
50 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,878 · 2020: $1,301 · 2021: $1,746 · 2022: $1,855 · 2023: $1,586 · 2024: $1,427 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,060 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,059.80 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,965.98 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,328.54 | 2019-2025 | |
| Amgen INC. | $1,089.57 | 2019-2022 | |
| Glaxosmithkline, LLC. | $711.15 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $647.64 | 2019-2024 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $583.46 | 2019-2024 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $394.87 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $348.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $280.89 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Janssen Pharmaceuticals, INC | $242.04 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $228.96 | 2019-2025 | Veozah |
| Genzyme Corporation | $224.82 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $206.41 | 2023-2025 | Rexulti |
| Currax Pharmaceuticals LLC | $196.75 | 2019-2023 | Nexletol, Contrave |
| Arbor Pharmaceuticals, INC. | $184.97 | 2019-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $183.77 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $163.52 | 2024 | Dupixent |
| Lundbeck LLC | $154.24 | 2024-2025 | Rexulti |
| Biogen, INC. | $145.34 | 2021-2023 | Spinraza |
| Kowa Pharmaceuticals America, INC. | $131.49 | 2019-2023 | Seglentis, Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $127.54 | 2019-2021 | |
| Abbott Laboratories | $124.81 | 2019 | |
| Daiichi Sankyo INC. | $122.72 | 2019-2025 | Injectafer |
| Novartis Pharmaceuticals Corporation | $114.27 | 2022-2025 | |
| Medtronic, INC. | $79.10 | 2025 | Percept PC Brainsense |
| Eisai INC. | $77.37 | 2020-2024 | |
| Cmp Pharma, INC. | $69.76 | 2023 | Tadliq, Carospir, Norliqva |
| Avanir Pharmaceuticals, INC. | $64.42 | 2019-2022 | |
| Esperion Therapeutics, INC. | $58.35 | 2023-2025 | Nexletol |
| Exact Sciences Corporation | $55.55 | 2023-2025 | Cologuard Collection Kit |
| Nalpropion Pharmaceuticals LLC | $53.14 | 2019 | |
| Corium, LLC | $51.93 | 2023 | Adlarity |
| Ironwood Pharmaceuticals, INC | $47.41 | 2022-2023 | Linzess |
| Renalytix Ai, INC. | $42.36 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Allergan, INC. | $40.41 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $37.18 | 2019 | |
| Seqirus USA INC | $29.29 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.23 | 2022 | |
| Ardelyx, INC. | $27.64 | 2024 | Ibsrela |
| Smith+Nephew, INC. | $23.34 | 2023 | Collagenase Santyl |
| Bayer Healthcare Pharmaceuticals INC. | $22.79 | 2025 | |
| Urovant Sciences INC | $21.68 | 2022 | |
| Intra-Sana Laboratories | $20.19 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Corcept Therapeutics | $19.73 | 2024 | Korlym |
| Sun Pharmaceutical Industries INC. | $18.22 | 2019 | |
| Dermira, INC. | $17.85 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.70 | 2020 | |
| Genentech USA, INC. | $14.66 | 2019 | |
| Acadia Pharmaceuticals INC | $14.14 | 2021 | |
| Radius Health, INC. | $12.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauro Gasparini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.